Evidence map›Paper›PMID 30843621›Full record

ArticleHistopathology2019

Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.

Ana P M Sebastiao, Fresia Pareja, Rahul Kumar, David N Brown, Catarina Silveira, Edaise M da Silva, Ju Y Lee, Angela Del, Nora Katabi, Simion Chiosea and 3 more

Open access · greenAbstract read
In one paragraph

Article in Histopathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools.Virchows Archiv : an international journal of pathology · 2024
    Review
  7. Article
  8. Problematic breast tumors reassessed in light of novel molecular data.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Ana P M SebastiaoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Fresia ParejaDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID https://orcid.org/0000-0003-3748-8049
Rahul KumarDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David N BrownDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Catarina SilveiraDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Edaise M da SilvaDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ju Y LeeDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Angela DelDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nora KatabiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Simion ChioseaDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Britta WeigeltDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jorge S Reis-FilhoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID https://orcid.org/0000-0003-2969-3173
Raja R SeethalaDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Memorial Sloan Kettering Cancer Center · USUniversity of Pittsburgh Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Breast Cancer Research FoundationNCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748
6 · The paper itself

Abstract

aimsPolymorphous adenocarcinoma (PAC) usually follows an indolent course, but some cases may show recurrences and high-grade features. The genetic events associated with recurrences and high-grade versions are yet to be defined. Our aim was to determine the genetic underpinning of recurrent PACs of the salivary gland and the repertoire of somatic genetic alterations in cases with high-grade histology. METHODS AND

resultsFour PACs from three patients, including one case with matching primary and recurrent tumours, one de-novo high-grade PAC, and a PAC that transformed to a high-grade tumour following multiple recurrences, were subjected to targeted sequencing (Memorial Sloan Kettering Mutation Profiling of Actionable Cancer Targets assay) or whole-exome sequencing. Both matching primary and recurrent tumours, and the de-novo high-grade PAC, harboured clonal PRKD1 E710D hotspot mutations, whereas the PAC that underwent high-grade transformation upon recurrence, which was wild-type for PRKD1, harboured a PRKD2 rearrangement. The PACs analysed here also harboured mutations targeting cancer genes such as PIK3CA, SETD2, ARID1A, and NOTCH2. A clonal decomposition analysis of the matching primary and recurrent PACs revealed that a minor subclone from the primary tumour became dominant in the recurrent tumour following a clonal selection evolutionary pattern.

conclusionsOur findings demonstrate that recurrent and high-grade PACs are underpinned by PRKD1 E710D hotspot mutations or PRKD2 rearrangements, and that recurrences of PACs may stem from the selection of pre-existing subclones in the primary tumour.

Indexed as

AdenocarcinomaAgedAged, 80 and overFemaleGene RearrangementGenomicsHumansMaleMiddle AgedMutationNeoplasm GradingNeoplasm Recurrence, LocalProtein Kinase CProtein Kinase D2Protein KinasesSalivary Gland NeoplasmsProtein Kinase Cprotein kinase DProtein Kinase D2Protein Kinasesnext-generation sequencingpolymorphous adenocarcinomaPRKD1PRKD2PRKD3whole-exome sequencing

Identifiers

PMID30843621
PMCPMC7920221
OpenAlexW2922026225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.